BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24291829)

  • 21. Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challenges.
    Thompson R; Drew CJ; Thomas RH
    Adv Protein Chem Struct Biol; 2012; 89():27-63. PubMed ID: 23046881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.
    van den Veyver IB; Eng CM
    Cold Spring Harb Perspect Med; 2015 Aug; 5(10):. PubMed ID: 26253094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomics: The search for association.
    Baker M
    Nature; 2010 Oct; 467(7319):1135-8. PubMed ID: 20981103
    [No Abstract]   [Full Text] [Related]  

  • 24. Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.
    Coonrod EM; Durtschi JD; Margraf RL; Voelkerding KV
    Arch Pathol Lab Med; 2013 Mar; 137(3):415-33. PubMed ID: 22770468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The occurrence of Guillain-Barré syndrome within families.
    Korn-Lubetzki I; Steiner I
    Neurology; 2005 May; 64(9):1665-6; author reply 1665-6. PubMed ID: 15883350
    [No Abstract]   [Full Text] [Related]  

  • 26. Whole Exome Sequencing: The Next Phase of Genetics Care.
    Mahon SM
    Oncol Nurs Forum; 2016 Mar; 43(2):249-52. PubMed ID: 26906136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing as a tool for Mendelian disease gene discovery.
    Bamshad MJ; Ng SB; Bigham AW; Tabor HK; Emond MJ; Nickerson DA; Shendure J
    Nat Rev Genet; 2011 Sep; 12(11):745-55. PubMed ID: 21946919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Personal genome analysis in amyotrophic lateral sclerosis].
    Tanaka F; Sone J; Atsuta N; Nakamura R; Doi H; Koyano S; Sobue G
    Brain Nerve; 2013 Mar; 65(3):257-65. PubMed ID: 23475517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome and whole-exome sequencing in neurological diseases.
    Foo JN; Liu JJ; Tan EK
    Nat Rev Neurol; 2012 Sep; 8(9):508-17. PubMed ID: 22847385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technology: Read the instructions.
    Scott AR
    Nature; 2016 Sep; 537(7619):S54-6. PubMed ID: 27602740
    [No Abstract]   [Full Text] [Related]  

  • 31. Trying to understand the genetics of atopic dermatitis.
    Stemmler S; Hoffjan S
    Mol Cell Probes; 2016 Dec; 30(6):374-385. PubMed ID: 27725295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What does individualized medicine mean today?].
    Erdmann E
    Dtsch Med Wochenschr; 2013 Mar; 138(13):658. PubMed ID: 23512368
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer genomics and inherited risk.
    Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
    J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular diagnosis of hereditary neurologic diseases. Position paper].
    Gasser T; Dichgans M; Jurkat-Rott K; Klockgether T; Klopstock T; Kretzschmar H; Lehmann-Horn F; Reichmann H; Rolfs A; Sander T; Stögbauer F
    Nervenarzt; 2000 Oct; 71(10):774-96. PubMed ID: 11082808
    [No Abstract]   [Full Text] [Related]  

  • 35. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The promise and reality of personal genomics.
    Yngvadottir B; Macarthur DG; Jin H; Tyler-Smith C
    Genome Biol; 2009; 10(9):237. PubMed ID: 19723346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
    Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
    Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exome sequencing: dual role as a discovery and diagnostic tool.
    Ku CS; Cooper DN; Polychronakos C; Naidoo N; Wu M; Soong R
    Ann Neurol; 2012 Jan; 71(1):5-14. PubMed ID: 22275248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting personal.
    Nature; 2008 Oct; 455(7216):1007. PubMed ID: 18948899
    [No Abstract]   [Full Text] [Related]  

  • 40. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.